BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19149122)

  • 1. [Age related macular degeneration and C-reactive protein].
    Stefan C; Dumitrica DM; Tebeanu E; Sapundgieva A; Dragomir L; Cristea I
    Oftalmologia; 2008; 52(3):73-6. PubMed ID: 19149122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.
    Kikuchi M; Nakamura M; Ishikawa K; Suzuki T; Nishihara H; Yamakoshi T; Nishio K; Taki K; Niwa T; Hamajima N; Terasaki H
    Ophthalmology; 2007 Sep; 114(9):1722-7. PubMed ID: 17400294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration.
    Vine AK; Stader J; Branham K; Musch DC; Swaroop A
    Ophthalmology; 2005 Dec; 112(12):2076-80. PubMed ID: 16225921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration.
    Thill M; Strunnikova NV; Berna MJ; Gordiyenko N; Schmid K; Cousins SW; Thompson DJ; Csaky KG
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2696-708. PubMed ID: 18515596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating inflammatory markers and hemostatic factors in age-related maculopathy: a population-based case-control study.
    Wu KH; Tan AG; Rochtchina E; Favaloro EJ; Williams A; Mitchell P; Wang JJ
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):1983-8. PubMed ID: 17460250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of lipoprotein parameters and C-reactive protein in patients with age-related macular degeneration.
    Colak E; Kosanović-Jaković N; Zorić L; Radosavljević A; Stanković S; Majkić-Singh N
    Ophthalmic Res; 2011; 46(3):125-32. PubMed ID: 21336002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.
    Seddon JM; George S; Rosner B; Rifai N
    Arch Ophthalmol; 2005 Jun; 123(6):774-82. PubMed ID: 15955978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of plasma homocysteine and risk of age-related macular degeneration.
    Seddon JM; Gensler G; Klein ML; Milton RC
    Am J Ophthalmol; 2006 Jan; 141(1):201-3. PubMed ID: 16387004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between C-reactive protein and age-related macular degeneration.
    Seddon JM; Gensler G; Milton RC; Klein ML; Rifai N
    JAMA; 2004 Feb; 291(6):704-10. PubMed ID: 14871913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration.
    Chau KY; Sivaprasad S; Patel N; Donaldson TA; Luthert PJ; Chong NV
    Eye (Lond); 2008 Jun; 22(6):855-9. PubMed ID: 18597988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of plasma-soluble fas ligand with aging and age-related macular degeneration.
    Jiang S; Moriarty-Craige SE; Li C; Lynn MJ; Cai J; Jones DP; Sternberg P
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1345-9. PubMed ID: 18385048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary cadmium and age-related macular degeneration.
    Erie JC; Good JA; Butz JA; Hodge DO; Pulido JS
    Am J Ophthalmol; 2007 Sep; 144(3):414-418. PubMed ID: 17631267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment of treatment efficacy in age related macular degeneration by evaluating the oxidative stress markers and OCT measurements.
    Dănulescu R; Costin D
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):328-33. PubMed ID: 24340512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eye's risk factors in age-related macular degeneration (AMD). Part II].
    Drobek-Słowik M; Karczewicz D; Safranow K
    Klin Oczna; 2008; 110(1-3):44-9. PubMed ID: 18669083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum dehydroepiandrosterone sulphate level in age-related macular degeneration.
    Tamer C; Oksuz H; Söğüt S
    Am J Ophthalmol; 2007 Feb; 143(2):212-216. PubMed ID: 17157799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum elastin-derived peptides in age-related macular degeneration.
    Sivaprasad S; Chong NV; Bailey TA
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3046-51. PubMed ID: 16123400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma is an independent risk for elevation of plasma C-reactive protein levels.
    Kasayama S; Tanemura M; Koga M; Fujita K; Yamamoto H; Miyatake A
    Clin Chim Acta; 2009 Jan; 399(1-2):79-82. PubMed ID: 18838067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eye's risk factors in age-related macular degeneration (AMD). Part I].
    Drobek-Słowik M; Karczewicz D; Safrano K
    Klin Oczna; 2008; 110(1-3):40-3. PubMed ID: 18669082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population.
    Sung SH; Chuang SY; Sheu WH; Lee WJ; Chou P; Chen CH
    Am J Cardiol; 2009 May; 103(10):1411-6. PubMed ID: 19427438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.